Fosaprepitant
EMEND FOR INJECTION
About: Fosaprepitant
Fosaprepitant belongs to the drug class of NK1 receptor antagonists. Fosaprepitant is used to block the NK1 receptor in the brain that triggers the desire to vomit. Fosaprepitant in combination with other antiemetics (5-HT3 receptor antagonists), work synergistically to suppress the worst measure of nausea and vomiting associated with chemotherapy. Indicated for children 6 months of age + & adults, Fosaprepitant can help prevent premature discontinuation of cancer treatment due to chemotherapy-induced nausea and vomiting (CINV).
INDICATIONS
Moderately Emetogenic Cancer Chemotherapy (MEC)
Fosaprepitant is used to treat acute or delayed nausea and vomiting linked with the initial or ongoing course of moderately emetogenic cancer chemotherapy. MEC is one of two groups of chemotherapy agents that cause the worst degree of nausea and vomiting.
(MEC) MEDICATIONS
Carboplatin
Clofarabine
Cyclophosphamide
Cytarabine
Irinotecan
Oxaliplatin
Highly Cancer Chemotherapy (HEC)
Fosaprepitant is used to treat acute and delayed nausea and vomiting linked with the initial or ongoing course of highly emetogenic cancer chemotherapy. HEC has the worst degree of nausea and vomiting, frequently linked as a leading cause of premature discontinuation of cancer treatment.
(HEC) MEDICATIONS
Carmustine
Cisplatin
Cyclophosphamide
Dacarbazine
COMMONLY PURCHASED TOGETHER
Azacitidine
Capecitabine
Carboplatin
Carmustine
Cisplatin
Clofarabine
Cyclophosphamide
Cytarabine
Dexamethasone
Erlotinib
Etoposide
Fluorouracil (5-FU)
Gemcitabine
Irinotecan
Methotrexate
Ondansetron
Oxaliplatin
Paclitaxel
Palonosetron
REQUEST MORE INFO
Delivering the medication
YOU NEED
WHEN YOU NEED IT
even during periods of
shortages in the market.
